Related Experiment Video

Updated: Sep 29, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Vaccines for the prevention of meningococcal disease in children

M Soriano-Gabarró1, James M Stuart, Nancy E Rosenstein

  • 1Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. zzd7@cdc.gov

Seminars in Pediatric Infectious Diseases
|August 30, 2002
PubMed

Insights

New meningococcal conjugate vaccines show promise for preventing serious childhood infections. These advanced vaccines offer improved efficacy in infants, potentially reducing the impact of meningococcal disease in the future.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Bacteriology

Background:

  • Neisseria meningitidis causes severe pediatric infections with high fatality and sequelae.
  • Current polysaccharide vaccines (A, C, Y, W-135) lack long-term efficacy in young children.
  • Serogroup B vaccines are under development; protein conjugation enhances infant immunogenicity.

Purpose of the Study:

  • To review the development and potential impact of new meningococcal conjugate vaccines.
  • To highlight the advantages of protein conjugation for pediatric vaccine efficacy.
  • To discuss the future outlook for reducing meningococcal disease burden.

Main Methods:

  • Review of current literature on meningococcal vaccines.
  • Analysis of vaccine development strategies, focusing on conjugation technology.
  • Examination of epidemiological data and vaccine impact studies.

Main Results:

  • Protein conjugation significantly improves vaccine efficacy in infants.
  • New conjugate vaccines targeting serogroups A, C, Y, and W-135 are in development.
  • A serogroup C conjugate vaccine is successfully implemented in the UK childhood schedule.

Conclusions:

  • Meningococcal conjugate vaccines are expected to significantly decrease disease incidence.
  • Advancements in vaccinology, particularly protein conjugation, are crucial for pediatric protection.
  • These vaccines represent a major step forward in controlling meningococcal disease globally.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...